{"id":"https://openalex.org/W7223811044","doi":"https://doi.org/10.26650/iuitfd.1884511","title":"REAL-WORLD OUTCOMES OF SECOND- AND THIRD-LINE THERAPIES AFTER FIRST-LINE VEGFR-TKI FAILURE IN METASTATIC RENAL CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE FROM T\u00dcRK\u0130YE","display_name":"REAL-WORLD OUTCOMES OF SECOND- AND THIRD-LINE THERAPIES AFTER FIRST-LINE VEGFR-TKI FAILURE IN METASTATIC RENAL CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE FROM T\u00dcRK\u0130YE","publication_year":2026,"publication_date":"2026-10-27","ids":{"openalex":"https://openalex.org/W7223811044","doi":"https://doi.org/10.26650/iuitfd.1884511"},"language":"en","primary_location":{"id":"doi:10.26650/iuitfd.1884511","doi":"https://doi.org/10.26650/iuitfd.1884511","is_oa":true,"landing_page_url":"https://doi.org/10.26650/iuitfd.1884511","pdf_url":null,"source":{"id":"https://openalex.org/S4210240261","display_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","issn_l":"1305-6433","issn":["1305-6433","1305-6441"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4","tr-dizin"],"host_organization":"https://openalex.org/P4310318354","host_organization_name":"Istanbul University","host_organization_lineage":["https://openalex.org/P4310318354"],"host_organization_lineage_names":["Istanbul University"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.26650/iuitfd.1884511","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020447403","display_name":"Beril Balci","orcid":"https://orcid.org/0000-0002-0985-6273","observed_orcids":["https://orcid.org/0000-0002-0985-6273"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Beril Balc\u0131 Topuz","raw_affiliation_strings":["SANKO University"],"raw_orcid":"https://orcid.org/0000-0002-0985-6273","affiliations":[{"raw_affiliation_string":"SANKO University","institution_ids":["https://openalex.org/I4210135744"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125979341","display_name":"Ahmet Tufekci","orcid":"https://orcid.org/0000-0002-8717-9562","observed_orcids":["https://orcid.org/0000-0002-8717-9562","https://orcid.org/0009-0009-6169-2956"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ahmet T\u00fcfek\u00e7i","raw_affiliation_strings":["SANKO University"],"raw_orcid":"https://orcid.org/0000-0002-8717-9562","affiliations":[{"raw_affiliation_string":"SANKO University","institution_ids":["https://openalex.org/I4210135744"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055812637","display_name":"Sibel Cangi","orcid":"https://orcid.org/0000-0002-1921-5621","observed_orcids":["https://orcid.org/0000-0002-1921-5621"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Sibel Cangi","raw_affiliation_strings":["SANKO University"],"raw_orcid":"https://orcid.org/0000-0002-1921-5621","affiliations":[{"raw_affiliation_string":"SANKO University","institution_ids":["https://openalex.org/I4210135744"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014887346","display_name":"\u00d6mer Ayd\u0131n Y\u0131ld\u0131r\u0131m","orcid":"https://orcid.org/0000-0002-7503-6361","observed_orcids":["https://orcid.org/0000-0002-7503-6361"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u00d6mer Ayd\u0131n Y\u0131ld\u0131r\u0131m","raw_affiliation_strings":["SANKO University"],"raw_orcid":"https://orcid.org/0000-0002-7503-6361","affiliations":[{"raw_affiliation_string":"SANKO University","institution_ids":["https://openalex.org/I4210135744"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047700570","display_name":"Mustafa Y\u0131ld\u0131r\u0131m","orcid":"https://orcid.org/0000-0002-4479-8136","observed_orcids":["https://orcid.org/0000-0002-4479-8136","https://orcid.org/0000-0003-4080-2465"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mustafa Y\u0131ld\u0131r\u0131m","raw_affiliation_strings":["SANKO University"],"raw_orcid":"https://orcid.org/0000-0002-4479-8136","affiliations":[{"raw_affiliation_string":"SANKO University","institution_ids":["https://openalex.org/I4210135744"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210135744"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80905866,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"89","issue":"4","first_page":"239","last_page":"246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":1.0},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8949999809265137},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9599999785423279},{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8100000023841858},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9760000109672546},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.902999997138977},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":1.0}],"concepts":[{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.9567000269889832},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9376999735832214},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9312999844551086},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.8847000002861023},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.8025000095367432},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.7791000008583069},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6992999911308289},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6348000168800354},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6071000099182129},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5073999762535095},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.48010000586509705},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.3569999933242798},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.32839998602867126},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3222000002861023},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.31520000100135803},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3095000088214874},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2806999981403351},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.2766999900341034},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.26809999346733093},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25679999589920044},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.2515999972820282}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26650/iuitfd.1884511","doi":"https://doi.org/10.26650/iuitfd.1884511","is_oa":true,"landing_page_url":"https://doi.org/10.26650/iuitfd.1884511","pdf_url":null,"source":{"id":"https://openalex.org/S4210240261","display_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","issn_l":"1305-6433","issn":["1305-6433","1305-6441"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4","tr-dizin"],"host_organization":"https://openalex.org/P4310318354","host_organization_name":"Istanbul University","host_organization_lineage":["https://openalex.org/P4310318354"],"host_organization_lineage_names":["Istanbul University"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.26650/iuitfd.1884511","doi":"https://doi.org/10.26650/iuitfd.1884511","is_oa":true,"landing_page_url":"https://doi.org/10.26650/iuitfd.1884511","pdf_url":null,"source":{"id":"https://openalex.org/S4210240261","display_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","issn_l":"1305-6433","issn":["1305-6433","1305-6441"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4","tr-dizin"],"host_organization":"https://openalex.org/P4310318354","host_organization_name":"Istanbul University","host_organization_lineage":["https://openalex.org/P4310318354"],"host_organization_lineage_names":["Istanbul University"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Istanbul Faculty of Medicine / \u0130stanbul T\u0131p Fak\u00fcltesi Dergisi","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W2019607817","https://openalex.org/W2023952988","https://openalex.org/W2047871200","https://openalex.org/W2099752220","https://openalex.org/W2105765452","https://openalex.org/W2115966993","https://openalex.org/W2116949558","https://openalex.org/W2149456801","https://openalex.org/W2162424705","https://openalex.org/W2222086386","https://openalex.org/W2316731546","https://openalex.org/W2726542547","https://openalex.org/W2792937256","https://openalex.org/W2893610840","https://openalex.org/W2908127196","https://openalex.org/W2911812451","https://openalex.org/W2913745075","https://openalex.org/W2944310467","https://openalex.org/W2967350775","https://openalex.org/W3037021593","https://openalex.org/W3134949580","https://openalex.org/W3150717587","https://openalex.org/W4295752719","https://openalex.org/W4322422773","https://openalex.org/W4379389239","https://openalex.org/W4392637925","https://openalex.org/W4398213922","https://openalex.org/W4400879351","https://openalex.org/W4404119826","https://openalex.org/W4408661714","https://openalex.org/W4409213261","https://openalex.org/W4412599465"],"related_works":["https://openalex.org/W2908127196","https://openalex.org/W3023624494","https://openalex.org/W7133204478","https://openalex.org/W4409945436","https://openalex.org/W4409826228","https://openalex.org/W7213366179","https://openalex.org/W3135423014","https://openalex.org/W3031880985","https://openalex.org/W4400228909","https://openalex.org/W3211251609"],"abstract_inverted_index":{"Objective:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3,8],"(ICIs)":[4],"and":[5,35,47,62,75,90,107,139,145,149,156,179,194,213,231,245],"tyrosine":[6],"kinase":[7],"(TKIs)":[9],"have":[10],"transformed":[11],"the":[12,31,131,169,182,219,237,251],"treatment":[13],"of":[14,33,72,115,127],"metastatic":[15],"renal":[16],"cell":[17],"carcinoma":[18],"(mRCC),":[19],"yet":[20],"access":[21],"limitations":[22],"continue":[23],"to":[24,234],"shape":[25],"real-world":[26],"practice.":[27],"This":[28,49],"study":[29,51],"evaluated":[30],"outcomes":[32,83,249],"second-":[34],"third-line":[36,176,252],"systemic":[37],"therapies":[38],"administered":[39],"after":[40,240],"TKI":[41,73,241],"failure":[42],"within":[43],"a":[44,122],"single-center":[45],"cohort.Materials":[46],"methods:":[48],"retrospective":[50],"included":[52],"50":[53],"patients":[54,65,135,164,174,210],"with":[55,121,192,197,228],"histologically":[56],"confirmed":[57],"mRCC":[58],"treated":[59],"between":[60],"2014":[61],"2024.":[63],"Eligible":[64],"had":[66,109],"received":[67,77,137],"at":[68,168,218],"least":[69],"one":[70,214],"line":[71],"therapy":[74,113],"subsequently":[76],"second-line":[78,238],"nivolumab":[79,138,153,167,225],"or":[80,118],"axitinib.":[81,142],"Survival":[82],"were":[84,100,147,181,216],"analyzed":[85],"using":[86],"Kaplan":[87],"\u2013":[88],"Meier":[89],"log-rank":[91],"tests.Results:":[92],"The":[93],"median":[94,123,200],"age":[95],"was":[96,189,202,226],"63":[97],"years;":[98],"76%":[99],"International":[101],"Metastatic":[102],"RCC":[103],"Database":[104],"Consortium":[105],"intermediate-risk,":[106],"82%":[108],"undergone":[110],"nephrectomy.":[111],"First-line":[112],"consisted":[114],"sunitinib":[116],"(72%)":[117],"pazopanib":[119],"(28%),":[120],"progression-free":[124],"survival":[125],"(PFS)":[126],"7":[128],"months.":[129],"In":[130,222],"second":[132],"line,":[133],"40":[134],"(80%)":[136],"10":[140,148],"(20%)":[141],"Median":[143,187],"PFS":[144,188,230],"OS":[146,201,232],"20":[150],"months":[151,158,191,196,204],"for":[152,159],"vs.":[154],"4":[155],"5":[157],"axitinib":[160,178,193,212,235,244],"(both":[161],"p<0.001).":[162],"Three":[163],"remained":[165],"on":[166],"data":[170],"cutoff.":[171],"Among":[172],"36":[173],"receiving":[175],"therapy,":[177],"cabozantinib":[180,246],"most":[183],"commonly":[184],"used":[185],"agents.":[186],"5.0":[190],"5.5":[195],"cabozantinib,":[198],"while":[199],"7.0":[203],"in":[205,236,250],"both":[206],"groups":[207],"(p>0.05).":[208],"Five":[209],"(four":[211],"cabozantinib)":[215],"alive":[217],"last":[220],"follow-up.Conclusion:":[221],"this":[223],"cohort,":[224],"associated":[227],"longer":[229],"compared":[233],"setting":[239],"failure,":[242],"whereas":[243],"demonstrated":[247],"similar":[248],"setting.":[253]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-10-28T00:00:00"}